楊明道馬宗聖<br /><br /><strong>【內容簡介】</strong> <br />講題一：Unintended Consequence of Restricting U.S. Software Patents–Deaths of Biotech and Other Patents Under § 101 <br />主講人：楊明道／Finnegan, Henderson, Farabow,Garrett & Dunner, LLP <br />《講 綱》 <br />一、Patent Eligibility Under 35 U.S.C. § 101 <br />二、Alice (2014) and Post-Alice Cases <br />三、Unintended Consequence After Alice <br />四、Is the Trend Reversing? <br />五、Takeaways <br /><br />講題二：Navigating Dire Straits: Prosecuting U.S. Patents to Minimize §112 and IPR Risks <br />主講人：馬宗聖／Finnegan, Henderson, Farabow,Garrett & Dunner, LLP <br />《講 綱》 <br />一、Principle for Indefiniteness <br />二、Nautilus On Remand at CAFC <br />三、Examiner Guidelines <br />四、Functional Claim Limitations <br />五、Planning for Claim Construction <br />六、Reissue <br /><br /><br />
<div id="gtx-trans" style="position: absolute; left: 379px; top: 453px;">
<div class="gtx-trans-icon"> </div>
</div>
